4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-25-028231
Options or other derivatives
- Director returned 182,484 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chell Jeffrey W. Director | 2025-03-31 | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | D: show line 1 in the form | ||
| Chell Jeffrey W. Director | 2025-03-31 | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | D: show line 2 in the form | ||
| Chell Jeffrey W. Director | 2025-03-31 | Returned to the company · Stock Option (Right to Buy) | −8,333 | 0 | D: show line 3 in the form | ||
| Chell Jeffrey W. Director | 2025-03-31 | Returned to the company · Stock Option (Right to Buy) | −8,333 | 0 | D: show line 4 in the form | ||
| Chell Jeffrey W. Director | 2025-03-31 | Returned to the company · Stock Option (Right to Buy) | −18,351 | 0 | D: show line 5 in the form | ||
| Chell Jeffrey W. Director | 2025-03-31 | Returned to the company · Stock Option (Right to Buy) | −72,156 | 0 | D: show line 6 in the form | ||
| Chell Jeffrey W. Director | 2025-03-31 | Returned to the company · Stock Option (Right to Buy) | −70,311 | 0 | D: show line 7 in the form |
Loading xslF345X05/ownership.xml…